21617 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules host-guest, closed hollow molecules, inclusion complexes, e.g. with cyclodextrins, clathrates, cavitates, fullerenes
Production of Lu-177 and other radionuclides via hot atom capture on nanostructured carbon
#2Self assembling molecules for targeted drug delivery
#3Therapeutic and imaging compositions and uses thereof
#4SELF ASSEMBLING MOLECULES FOR TARGETED DRUG DELIVERY
#5Therapeutic and imaging compositions and uses thereof
#6Method for collecting metal-containing fullerene
#7Polymers functionalized with ion-specific recognition elements
#8Therapeutic compositions and methods for targeted delivery of active agents
#9CONTROLLABLE RELEASE COMPOSITION AND METHOD FOR PREPARING SAME
#10ANTISENSE COMPOUNDS AND METHODS FOR DIAGNOSTIC IMAGING
#11SUPRAMOLECULAR BIOCONJUGATES
#12Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent
#13PREPARATION OF CARBON NANOTUBES WITH LANTHANOID CATALYSTS
#14Polymers functionalized with ion-specific recognition elements
#15Breath test device and method
#16Polymer-coated paramagnetic particles
#17NOVEL NANOPARTICLES AND USE THEREOF
#18Diagnostic agents for pancreatic exocrine function
#19Method for preparing particles of radioactive powder containing Cesium-131 for use in brachytherapy sources
#20Lapachone delivery systems, compositions and uses related thereto
#21Compounds and methods for diagnostic imaging and therapy
#22Antibodies specific for nanotubes and related methods and compositions
#23Diagnostic agents for pancreatic exocrine function
#24Diagnostic agents for pancreatic exocrine function
#25Diagnostic agents for pancreatic exocrine function
#26Radiopharmaceuticals including encapsulated GA+Tc